SUD Treatment Billing 2026: Reimbursement Models & Insurance Authorization Guide | 247 MBS

SUD Treatment Billing 2026: New Reimbursement Models & Insurance Authorization Requirements

Substance use disorder (SUD) treatment billing has entered one of its most transformative periods. The convergence of stricter Mental Health Parity and Addiction Equity Act (MHPAEA) enforcement, updated 42 CFR Part 2 confidentiality regulations, expanded Medicare coverage for medication-assisted treatment, and the ongoing shift toward value-based reimbursement models is creating both significant revenue opportunities and compliance risks for SUD treatment providers in 2026. For providers already navigating SUD billing challenges, the stakes have never been higher.

The financial opportunity is substantial. Reimbursement rates for many psychological and SUD services increased approximately 4% under the 2026 Medicare Physician Fee Schedule, and the expansion of telehealth for SUD treatment continues to open new billing pathways. However, 43% of codes billed by addiction specialist physicians are now subject to efficiency adjustments, behavioral health claims face heightened audit scrutiny, and insurers continue to deploy aggressive utilization management on higher levels of care.

This guide covers every billing change that matters for SUD treatment providers in 2026, including the new reimbursement models, verified ICD-10 codes, authorization requirements across payers, and practical strategies to maximize collections while staying compliant. Whether you are an established treatment center or a physician practice offering office-based SUD services, following these best practices for accurate SUD medical billing will directly impact your bottom line.

The 2026 SUD Billing Regulatory Landscape

MHPAEA Parity Enforcement: The Game-Changer

The most consequential regulatory development for SUD billing in 2026 is the full enforcement of the updated Mental Health Parity and Addiction Equity Act (MHPAEA) final rules. Effective for plan years beginning on or after January 1, 2026, these rules fundamentally change how insurers can manage SUD and mental health benefits.

Non-Quantitative Treatment Limitations (NQTLs): Health plans can no longer apply prior authorization requirements, network composition standards, or reimbursement methodologies to SUD/mental health benefits that are more restrictive than those applied to medical/surgical benefits in the same classification. This means if a plan does not require prior authorization for outpatient surgical procedures, it cannot require prior authorization for outpatient SUD treatment at the same benefit level.

Data Collection and Comparative Analysis: Plans must now collect and evaluate data on access to SUD/mental health benefits compared to medical/surgical benefits. If the data reveals material differences in access resulting from NQTLs, plans must take reasonable action to address the disparity.

Meaningful Benefits Standard: Plans must provide meaningful benefits for SUD/mental health conditions in every classification where medical/surgical benefits are provided. This prevents plans from offering token SUD coverage that does not actually meet treatment needs.

For a comprehensive overview of how these parity rules intersect with billing compliance, see our complete 2026 guide to mental health billing compliance and parity laws.

42 CFR Part 2 Updates: Effective February 16, 2026

The updated 42 CFR Part 2 regulations, which govern the confidentiality of SUD treatment records, took full effect on February 16, 2026. The most significant billing-related changes include: alignment of Part 2 with HIPAA, allowing SUD treatment records to be used for treatment, payment, and healthcare operations (TPO) with patient consent; a single consent form that covers all future TPO uses rather than requiring consent for each individual disclosure; and a prohibition on using SUD records in legal proceedings against patients without a specific court order.

For billing teams, this means SUD treatment information can now flow more freely for insurance billing purposes once the patient signs a compliant consent form. However, the consent requirements are stricter than standard HIPAA authorization, and failing to obtain proper consent before submitting claims can result in federal penalties. Every SUD treatment facility should update its intake consent forms to comply with the revised Part 2 requirements.

Medicare Conversion Factor and Efficiency Adjustments

The 2026 MPFS conversion factor increased to approximately $33.42 for non-qualifying APM practitioners (a ~4% increase), providing a welcome reimbursement boost for SUD services. However, 43% of codes commonly billed by addiction specialist physicians are subject to work RVU efficiency adjustments. The good news is that the top codes billed by addiction specialists in 2024, representing about 71% of services by volume, are not subject to these adjustments, meaning the net impact on most SUD practices is positive.

Complete SUD Treatment Billing Code Reference for 2026

Outpatient SUD Treatment CPT Codes

CPT/HCPCS Code	Description	2026 Rate Range	Common Use
90791	Psychiatric diagnostic evaluation	$150 – $250	Initial SUD assessment
90792	Psychiatric diagnostic eval with medical services	$175 – $275	Assessment with physical exam
90832	Individual psychotherapy, 30 min	$65 – $95	Brief individual counseling
90834	Individual psychotherapy, 45 min	$95 – $140	Standard individual session
90837	Individual psychotherapy, 60 min	$130 – $190	Extended individual session
90839	Psychotherapy for crisis, first 60 min	$145 – $210	Crisis intervention
90840	Psychotherapy for crisis, each addl 30 min	$70 – $105	Add-on to 90839
90853	Group psychotherapy	$30 – $55	Group therapy sessions
99408	SBIRT, 15-30 min	$35 – $50	Screening & brief intervention
99409	SBIRT, >30 min	$65 – $90	Extended screening & intervention

 

Medication-Assisted Treatment (MAT) Codes

HCPCS Code	Description	Billing Context
G2067	Medication-assisted treatment, methadone (OTP weekly bundle)	Opioid Treatment Programs only
G2068	Medication-assisted treatment, buprenorphine oral (OTP bundle)	Opioid Treatment Programs only
G2069	MAT, buprenorphine injection (OTP bundle)	Long-acting injectable buprenorphine
G2070	MAT, buprenorphine implant (OTP bundle)	Subdermal implant provision
G2071	MAT, naltrexone injection (OTP bundle)	Extended-release naltrexone
G2076	Intake activity, including initial assessment (OTP add-on)	First visit at OTP
G2213	Initiation of OUD medication in emergency department	ED-based MAT initiation

 

Medicaid H-Codes for SUD Services

Medicaid is now the single largest payer for behavioral health services in the US, and SUD billing through Medicaid relies heavily on HCPCS H-codes. Practices that serve Medicaid populations should be proficient in these codes, which differ significantly from the CPT codes used by Medicare and commercial payers. For a detailed walkthrough of procedure code usage, see our guide to mastering procedure codes for outpatient substance abuse treatment.

H-Code	Description	Level of Care
H0001	Alcohol and/or drug assessment	All levels
H0004	Behavioral health counseling and therapy, per 15 min	Outpatient individual
H0005	Alcohol and/or drug services; group counseling	Outpatient group
H0015	Alcohol and/or drug services; intensive outpatient (per day)	IOP (Level 2.1)
H0018	Short-term residential SUD treatment (per diem)	Residential (Level 3.1-3.5)
H0019	Long-term residential SUD treatment (per diem)	Residential (Level 3.5+)
H0020	Alcohol and/or drug services; methadone administration	OTP methadone dosing
H0038	Self-help/peer services, per 15 min	Recovery support

 

Verified ICD-10-CM Codes for SUD Treatment Billing

Accurate ICD-10-CM coding is critical for SUD claims. Using the wrong code category (abuse vs. dependence vs. use) or insufficient specificity is one of the top reasons for SUD claim denials. The following codes are verified against the current CMS ICD-10-CM database.

Opioid Use Disorders (F11 Category)

ICD-10 Code	Description	Clinical Scenario
F11.10	Opioid abuse, uncomplicated	Active opioid misuse without dependence
F11.14	Opioid abuse with opioid-induced mood disorder	Abuse with depression/anxiety
F11.20	Opioid dependence, uncomplicated	Active opioid dependence (MAT primary dx)
F11.21	Opioid dependence, in remission	Maintained on MAT, stable recovery
F11.24	Opioid dependence with opioid-induced mood disorder	Dependence with comorbid mood disorder
F11.282	Opioid dependence with opioid-induced sleep disorder	Dependence with insomnia/sleep disruption
F11.288	Opioid dependence with other opioid-induced disorder	Dependence with other complications

 

Alcohol Use Disorders (F10 Category)

ICD-10 Code	Description	Clinical Scenario
F10.10	Alcohol abuse, uncomplicated	Active alcohol misuse without dependence
F10.20	Alcohol dependence, uncomplicated	Active alcohol dependence
F10.21	Alcohol dependence, in remission	Recovery/maintenance phase
F10.231	Alcohol dependence with withdrawal delirium	Acute withdrawal (inpatient level)
F10.24	Alcohol dependence with alcohol-induced mood disorder	Dependence with depression/mania
F10.280	Alcohol dependence with alcohol-induced anxiety disorder	Dependence with comorbid anxiety
F10.282	Alcohol dependence with alcohol-induced sleep disorder	Dependence with sleep disruption

 

Other Substance Use Disorders

ICD-10 Code	Description	Substance
F14.10	Cocaine abuse, uncomplicated	Cocaine
F14.20	Cocaine dependence, uncomplicated	Cocaine
F15.10	Other stimulant abuse, uncomplicated	Methamphetamine/stimulants
F15.20	Other stimulant dependence, uncomplicated	Methamphetamine/stimulants
F12.10	Cannabis abuse, uncomplicated	Cannabis
F12.20	Cannabis dependence, uncomplicated	Cannabis
F13.20	Sedative/hypnotic/anxiolytic dependence, uncomplicated	Benzodiazepines/sedatives
F19.20	Other psychoactive substance dependence, uncomplicated	Polysubstance/NOS

 

Coding Alert: The distinction between "abuse" (F1x.1x), "dependence" (F1x.2x), and "use, unspecified" (F1x.9x) is critical. "Use, unspecified" codes (like F11.90) carry the lowest level of clinical severity and will often not support medical necessity for intensive services like residential treatment or IOP. Always code to the documented clinical severity. For coding best practices, our guide on correctly coding to prevent ICD-10 denials provides essential specificity guidance.

Insurance Authorization Requirements for SUD Treatment in 2026

Authorization requirements for SUD treatment vary dramatically by payer, level of care, and state. Despite MHPAEA parity requirements, SUD services remain among the most heavily managed by insurers. Understanding these requirements is essential to avoiding denials.

Authorization Requirements by Level of Care

ASAM Level	Service Type	Typical PA Required?	Concurrent Review
0.5	Early intervention (SBIRT)	Rarely	None
1.0	Outpatient treatment	Sometimes (varies by payer)	Rare
2.1	Intensive outpatient (IOP)	Almost always	Every 2-4 weeks
2.5	Partial hospitalization (PHP)	Always	Every 1-2 weeks
3.1	Clinically managed low-intensity residential	Always	Every 3-7 days
3.5	Clinically managed high-intensity residential	Always	Every 3-5 days
3.7	Medically monitored intensive inpatient	Always	Every 1-3 days
4.0	Medically managed intensive inpatient	Always	Daily

 

The higher the level of care, the more aggressive the utilization management. Commercial payers in particular offset higher reimbursement rates with strict prior authorization requirements and frequent concurrent reviews. For a complete overview of how to navigate authorization efficiently, see our guide to all you need to know about prior authorizations.

Key Payer Differences

Medicare: Medicare covers SUD services including screening (SBIRT), outpatient counseling, IOP (newly covered), MAT through OTPs, and office-based OUD treatment. Traditional Medicare FFS generally does not require prior authorization for outpatient SUD services, but Medicare Advantage plans often do. OTPs bill bundled weekly rates directly to Medicare.

Medicaid: As the largest SUD payer nationally, Medicaid coverage is extensive but complex. Most states deliver SUD benefits through managed care organizations (MCOs), each with their own authorization requirements, provider manuals, and claims processing protocols. Providers must verify requirements with the specific MCO, not just the state Medicaid program.

Commercial Payers: Commercial plans typically offer the highest reimbursement rates but also deploy the most aggressive utilization management. Expect prior authorization for all residential and IOP services, concurrent reviews at regular intervals, and step-down requirements that mandate failed lower-level treatment before approving higher levels of care.

8 Best Practices for SUD Treatment Billing in 2026

1. Use ASAM Criteria to Justify Level of Care

The American Society of Addiction Medicine (ASAM) Criteria is the standard framework payers use to evaluate medical necessity for SUD treatment. Document your clinical assessment using ASAM dimensions (acute intoxication/withdrawal, biomedical conditions, emotional/behavioral conditions, readiness to change, relapse potential, and recovery environment) and explicitly match your recommended level of care to the ASAM criteria. This documentation is your primary defense against utilization management denials.

2. Code to Maximum Clinical Severity

Never default to "use, unspecified" codes when clinical documentation supports abuse or dependence. Use F11.20 (opioid dependence) rather than F11.90 (opioid use, unspecified) when dependence criteria are met. Code comorbid conditions separately, as co-occurring mental health diagnoses (F32.1 for moderate depressive episode, F41.1 for generalized anxiety disorder) strengthen medical necessity for comprehensive treatment. Polysubstance use should be coded for each individual substance.

3. Master Telehealth SUD Billing

Medicare continues to cover SUD services via telehealth, including audio-only visits, with no geographic restrictions. The place of service code for telehealth is POS 10 (telehealth in patient home) or POS 02 (telehealth other). Modifier 95 (synchronous telemedicine) is required. For SUD-specific telehealth billing nuances, see our guide to telehealth billing rules for SUD treatment in 2026.

4. Implement Concurrent Review Workflows

For IOP, PHP, and residential levels of care, payer-required concurrent reviews determine continued authorization. Build a workflow that tracks review due dates, assigns clinical staff to complete utilization review documentation at least 48 hours before the review deadline, and documents ongoing medical necessity using measurable outcomes (withdrawal symptom scales, PHQ-9 scores, drug screening results, treatment plan progress).

5. Understand 42 CFR Part 2 Consent Requirements

Ensure your intake process obtains compliant consent for disclosure of SUD treatment records for payment purposes. The updated Part 2 regulations allow a single consent covering all future TPO uses, but the consent form must meet specific requirements including naming the entities to which information may be disclosed. Billing SUD claims without proper consent exposes your facility to federal penalties.

6. Leverage MHPAEA Parity in Denials and Appeals

When a payer denies SUD authorization using criteria that appear more restrictive than those applied to medical/surgical benefits, cite MHPAEA parity requirements in your appeal. For example, if a plan requires prior authorization for outpatient SUD counseling but not for outpatient physical therapy, that is a potential parity violation. Document the comparison and file the appeal. For appeal strategies, see our tips to appeal denied claims.

7. Verify Eligibility and Benefits Before Every Admission

SUD benefits vary widely even within the same payer. Always verify the specific SUD benefit structure, including covered levels of care, day/visit limits, out-of-pocket maximums, network status, and authorization requirements before admitting a patient. This single step prevents more revenue loss than any other billing practice. Our guide on eligibility verification to reduce denials covers the full verification workflow.

8. Track Denial Patterns by Payer and Service

Establish a denial tracking system that categorizes denials by payer, ASAM level, denial reason, and outcome. This data reveals systemic issues: if a specific payer consistently denies IOP authorizations after day 14, you know to front-load your strongest clinical documentation in the first two concurrent reviews. For guidance on building these systems, see our step-by-step guide for SUD billing.

Common SUD Billing Mistakes That Cost Providers Money

The most expensive SUD billing errors include: using "use, unspecified" ICD-10 codes when clinical documentation supports abuse or dependence; failing to obtain compliant 42 CFR Part 2 consent before submitting claims; missing concurrent review deadlines (resulting in immediate authorization termination); not documenting ASAM-level medical necessity for the requested level of care; billing group therapy (90853) at individual session rates; failing to verify SUD-specific benefits before admission; not appealing denials using MHPAEA parity arguments; and using the wrong H-code or CPT code for the service level delivered. For practices struggling with these issues, understanding the complete landscape of navigating mental health billing challenges is essential.

Frequently Asked Questions (FAQ) — SUD Treatment Billing 2026

Q1: What ICD-10 codes are used for opioid use disorder billing?

The primary ICD-10-CM codes for OUD include F11.10 (opioid abuse, uncomplicated), F11.20 (opioid dependence, uncomplicated), F11.21 (opioid dependence, in remission), and F11.24 (opioid dependence with opioid-induced mood disorder). Always code to the documented clinical severity rather than defaulting to F11.90 (opioid use, unspecified).

Q2: Does Medicare cover substance use disorder treatment?

Yes. Medicare covers SUD screening (SBIRT via CPT 99408/99409), outpatient counseling (90832-90837), intensive outpatient programs (IOP), medication-assisted treatment through enrolled Opioid Treatment Programs (bundled G-codes), and office-based OUD treatment. Audio-only telehealth is also covered for SUD services with no geographic restrictions.

Q3: What is 42 CFR Part 2 and how does it affect SUD billing in 2026?

42 CFR Part 2 governs the confidentiality of SUD treatment records. Updated regulations effective February 16, 2026 now align Part 2 more closely with HIPAA, allowing SUD records to be used for treatment, payment, and healthcare operations (TPO) with a single patient consent. However, the consent requirements are stricter than standard HIPAA authorization, and billing without proper consent can result in federal penalties.

Q4: How does MHPAEA parity affect SUD treatment authorization in 2026?

The MHPAEA final rules effective January 1, 2026 prohibit health plans from applying prior authorization requirements or other NQTLs to SUD/mental health benefits that are more restrictive than those applied to medical/surgical benefits. Plans must also collect data comparing access to SUD vs. medical benefits and address material disparities.

Q5: What CPT codes are used for SUD group therapy billing?

Group psychotherapy for SUD is billed using CPT 90853, which reimburses approximately $30-$55 per patient per session. Group therapy is per-patient billing, not per-group. For Medicaid, H0005 (alcohol/drug group counseling) is commonly used. Never bill individual therapy codes (90832-90837) for group sessions.

Q6: What is the ASAM Criteria and why does it matter for billing?

The ASAM (American Society of Addiction Medicine) Criteria is the standard framework for determining appropriate levels of SUD care. It evaluates patients across six dimensions to recommend placement at ASAM levels 0.5 through 4.0. Payers use ASAM criteria to evaluate medical necessity for authorization and continued stay reviews. Documentation that aligns with ASAM dimensions is essential for approval.

Q7: How do OTPs bill Medicare for MAT services?

Opioid Treatment Programs bill Medicare using bundled weekly HCPCS G-codes (G2067 for methadone, G2068 for oral buprenorphine, G2069 for injectable buprenorphine, G2071 for injectable naltrexone). These bundles include the medication, dispensing, counseling, and toxicology testing for the week. OTPs must be enrolled with CMS and bill directly.

Q8: Which SUD services require prior authorization?

Authorization requirements vary by payer. Generally: SBIRT and outpatient counseling rarely require PA. IOP (ASAM Level 2.1) almost always requires PA. PHP (Level 2.5) and all residential levels (3.1-4.0) always require PA with concurrent reviews every 1-7 days depending on level. Commercial payers are the most aggressive, while traditional Medicare FFS generally does not require PA for outpatient SUD services.

Q9: What are the Medicaid H-codes for SUD billing?

Key Medicaid H-codes include H0001 (SUD assessment), H0004 (individual behavioral health counseling, per 15 min), H0005 (SUD group counseling), H0015 (IOP per day), H0018 (short-term residential, per diem), H0019 (long-term residential, per diem), H0020 (methadone administration), and H0038 (peer support services). Requirements vary by state MCO.

Q10: How can I reduce SUD claim denials?

The most effective strategies include: documenting ASAM-level medical necessity, coding to maximum clinical severity, obtaining 42 CFR Part 2 compliant consent, verifying SUD-specific benefits before admission, tracking concurrent review deadlines, using MHPAEA parity arguments in appeals, and implementing denial pattern tracking by payer and service type. Practices consistently applying these strategies report 30-40% fewer denials.